Ambuja Cements (AMBUJACEM) — Board Meeting

Ambuja Cements' Board approved on December 22, 2025 two amalgamation schemes: ACC Limited (revenue ₹21,668 crores, net worth ₹18,271 crores) merging into Ambuja, and Orient Cement Limited (revenue ₹2,709 crores, net worth ₹1,808 crores) merging into Ambuja. ACC shareholders receive 328 Ambuja shares per 100 ACC shares; Orient shareholders receive 33 Ambuja shares per 100 Orient shares. Both are Adani subsidiaries. Post-merger, Ambuja's promoter stake drops from 67.65% to 61.63% (post-ACC), with public holding rising to 38.32%. The schemes unlock operational synergies, streamline group structure, and require NCLT and stock exchange approvals.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this board meeting affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 22 December 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 22 December 2025

SBICARD SBI Cards and Payment Services Limited Corporate Action TATASTEEL Tata Steel Limited Corporate Action WIPRO Wipro Limited Corporate Action OBEROIRLTY Oberoi Realty Limited Financial Results MOTHERSON Samvardhana Motherson International Limited Board Meeting SHRIRAMFIN Shriram Finance Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.